Do serum prolactin levels correlate with antibodies against desmoglein in pemphigus vulgaris?

Authors

1 Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Dermatology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran

Abstract

Background: Pemphigus vulgaris is a chronic inflammatory disease of skin, the etiology of which is not completely known. Despite the latter, anti-desmoglein antibodies play a proven role in the pathogenesis. Recent studies showed an etiologic effect for prolactin in the pemphigus vulgaris. This study aimed to quantify the correlation between serum prolactin levels and anti-desmoglein antibodies in patients with pemphigus vulgaris.
Materials and Methods: Prolactin and antibodies against desmoglein 1 and 3 measured with ELISA in 14 new subjects of pemphigus vulgaris.
Results: There was no statistically significant relation between both serum prolactin and anti-desmoglein1 levels (r = 0.02, P = 0.47) and serum prolactin and anti-desmoglein 3 levels (r= -0.09, P = 0.38).
Conclusion: This study indicates that no correlation was found between serum prolactin levels and anti-desmoglein 1 levels and serum prolactin and anti-desmoglein 3 levels. However, other studies should be initiated regarding exact molecular and cellular effects of prolactin in the pathogenesis of pemphigus vulgaris.

Keywords

1.
Amagai M. Pemphigus. In: Bolognia JL, Jorrizo JL, Schaffer JV, editors. Dermatology. 3rd ed. Netherlands: Elsevier; 2012. p. 461-74.  Back to cited text no. 1
    
2.
Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombet SJ, Black MM. Diagnosis of pemphigus by ELISA: A critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000;25:236-40.  Back to cited text no. 2
    
3.
Fine JD. Prevalence of autoantibodies to bullous pemphigoid antigens within the normal population. Arch Dermatol 2010;146:74-5.  Back to cited text no. 3
    
4.
Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007;11:462-81.  Back to cited text no. 4
    
5.
Femiano F. Pemphigus vulgaris: Recent advances in our understanding of its pathogenesis. Minerva Stomatol 2007;56:215-23.  Back to cited text no. 5
    
6.
Anhalt GJ, Díaz LA. Pemphigus vulgaris-a model for cutaneous autoimmunity. J Am Acad Dermatol 2004;51 (1 Suppl):S20-1.  Back to cited text no. 6
    
7.
Liu Z, Li N, Diaz LA. Immunopathological mechanisms of acantholysis in pemphigus vulgaris: An explanation by ultrastructural observations. J Invest Dermatol 2004;122:13-4.  Back to cited text no. 7
    
8.
Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 1998;110:76-8.  Back to cited text no. 8
    
9.
Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007;6:537-42.  Back to cited text no. 9
    
10.
Vera-Lastra O, Jara LJ, Espinoza LR. Prolactin and autoimmunity. Autoimmun Rev 2002;1:360-4.  Back to cited text no. 10
    
11.
Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, et al. Prolactin and Autoimmunity. Clin Rev Allergy Immunol 2012;42:189-98.  Back to cited text no. 11
    
12.
Krause I, Blumenfeld Z, Malchinsky M, Cohen S, Blank M, Eldor A, et al. Anti endothelial cell antibodies in the sera of hyper- prolactinemic women. Lupus 1998;7:377-82.  Back to cited text no. 12
    
13.
Khandpur S, Reddy BS. An unusual association of pemphigus vulgaris with hyperprolactinemia. Int J Dermatol 2002;41:696-9.  Back to cited text no. 13
    
14.
Avci A, Avcı D. Serum Prolactin Levels in Behçet's Disease. Is There a Relationship between Behcet's Disease and Prolactin as in Other Autoimmune Diseases? Acta Dermatovenerol Croat 2013;21:52-3.  Back to cited text no. 14
    
15.
Kumar B, Arora S, Kumaran MS, Jain R, Dogra S. Study of desmoglein 1 and 3 antibody levels in relation to severity in Indian patients with pemphigus. Indian J Dermatol Venereol Leprol 2006;72:203-6.  Back to cited text no. 15
[PUBMED]  Medknow Journal  
16.
Mortazavi H, Kiavash K, Chams-Davatchi NE. Correlation of pemphigus vulgaris antibody titers by indirect immunofluorescence with activity of disease based on pemphigus area and activity score (PAAS). Acta Med Iranica 2008;46-7.  Back to cited text no. 16
    
17.
Leanos-Miranda A, Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology 2006;45:97-101.  Back to cited text no. 17
    
18.
Rezaieyazdi Z, Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int 2006;26:1036-9.  Back to cited text no. 18
    
19.
Praprotnik S, Agmon-Levin N, Porat-Katz B, Blank M, Meroni P, Cervera R, et al. Prolactin's role in the pathogenesis of the antiphospholipid syndrome. Lupus 2010;19:1515-9.  Back to cited text no. 19
    
20.
Fallahzadeh MK, Lashkarizadeh H, Kamali-Sarvestani E, Namazi MR. Elevation of serum prolactin levels in patients with pemphigus vulgaris: A novel finding with practical implications. J Am Acad Dermatol 2010;62:1071-2.  Back to cited text no. 20
    
21.
Azizzadeh M, Malek Mojtaba A, Ghorbani R. Does prolactin indicate severity of psoriasis? Iran J Dermatol 2009;12:79-81.  Back to cited text no. 21